Chest pain - A strong predictor of adverse cardiac events following percutaneous intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISTENT])

Mark A. Robbins; Steven P. Marso; Kathy Wolski; John Peterson; A. Michael Lincoff; Sorin Brener

doi:10.1016/S0002-9149(99)00572-X

Chest pain - A strong predictor of adverse cardiac events following percutaneous intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISTENT])

Mark A. Robbins, Steven P. Marso, Kathy Wolski, John Peterson, A. Michael Lincoff, Sorin Brener

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1350-1353
Number of pages	4
Journal	American Journal of Cardiology
Volume	84
Issue number	11
DOIs	https://doi.org/10.1016/S0002-9149(99)00572-X
State	Published - Dec 1 1999

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/S0002-9149(99)00572-X

Cite this

Chest pain - A strong predictor of adverse cardiac events following percutaneous intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISTENT]). / Robbins, Mark A.; Marso, Steven P.; Wolski, Kathy et al.
In: American Journal of Cardiology, Vol. 84, No. 11, 01.12.1999, p. 1350-1353.

Research output: Contribution to journal › Article › peer-review

@article{a20212935eac427d81470d5d573e8360,

title = "Chest pain - A strong predictor of adverse cardiac events following percutaneous intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISTENT])",

author = "Robbins, {Mark A.} and Marso, {Steven P.} and Kathy Wolski and John Peterson and Lincoff, {A. Michael} and Sorin Brener",

year = "1999",

month = dec,

day = "1",

doi = "10.1016/S0002-9149(99)00572-X",

language = "English (US)",

volume = "84",

pages = "1350--1353",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "11",

}

TY - JOUR

T1 - Chest pain - A strong predictor of adverse cardiac events following percutaneous intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISTENT])

AU - Robbins, Mark A.

AU - Marso, Steven P.

AU - Wolski, Kathy

AU - Peterson, John

AU - Lincoff, A. Michael

AU - Brener, Sorin

PY - 1999/12/1

Y1 - 1999/12/1

UR - http://www.scopus.com/inward/record.url?scp=0032755377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032755377&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(99)00572-X

DO - 10.1016/S0002-9149(99)00572-X

M3 - Article

C2 - 10614805

AN - SCOPUS:0032755377

SN - 0002-9149

VL - 84

SP - 1350

EP - 1353

JO - American Journal of Cardiology

JF - American Journal of Cardiology

IS - 11

ER -

Chest pain - A strong predictor of adverse cardiac events following percutaneous intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISTENT])

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this